Camellia (CAM) AI Stock Analysis

• Market Cap: £144.08M
• Dividend Yield: 4.56%
• Average Volume (3M): 424.00
• Price to Earnings (P/E): ―
• Beta (1Y): 0.43
• Revenue Growth: -3.71%
• EPS Growth: -15.89%
• Country: UK
• Employees: 79,254
• Sector: Consumer Defensive
• Sector Strength: 50
• Industry: Agricultural Farm Products
• EPS (TTM): 3.37
• Shares Outstanding: 2,527,795
• 10 Day Avg. Volume: 686
• 30 Day Avg. Volume: 424
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £5,689.00
• Price Target Upside: -0.63% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 55 Neutral
• Price Target: 5,689.00p ▼(-0.63% Downside)

Camellia's overall stock score reflects significant financial challenges, with persistent losses and liquidity issues overshadowing potential technical and strategic improvements. While the technical analysis suggests some short-term bullish momentum, and corporate actions like share buybacks and strategic plans are positive, the underlying financial weakness and valuation concerns weigh heavily on the score. The absence of earnings call data limits insights into management's outlook, further emphasizing the need for caution.

Camellia Business Overview & Revenue Model

Company Description

Camellia (CAM) is a diversified company engaged in various sectors including agriculture, healthcare, and real estate. The company primarily focuses on the cultivation and processing of tea and horticultural products, while also investing in healthcare services and property development. Its core products include premium tea varieties, wellness products, and residential and commercial real estate solutions.

How the Company Makes Money

Camellia generates revenue through multiple key streams. In the agricultural sector, the company profits from the sale of tea and horticultural products, leveraging its established brand and global distribution channels. The healthcare division contributes to revenue by providing specialized services and products, catering to a growing demand for health and wellness solutions. Additionally, Camellia earns income from its real estate investments, including rental income from properties and profits from property sales. The company has formed strategic partnerships with retailers and distributors, enhancing its market reach and driving sales. Seasonal trends and consumer preferences also significantly influence its earnings, as demand for premium tea and health-related products can fluctuate throughout the year.

Camellia Financial Statement Overview

Summary

Camellia's financial performance reflects substantial challenges. The income statement indicates ongoing profitability issues with declining revenues and persistent net losses. The balance sheet shows a solid equity position but signs of asset and equity erosion. Cash flow analysis reveals consistently negative cash flow from operations, indicating potential liquidity issues. While the company maintains adequate liquidity through cash reserves, the financial trajectory suggests a need for strategic adjustments to improve profitability and cash generation.

Income Statement

Camellia's income statement reveals a challenging landscape with declining revenues and negative net income over the last several years, indicating persistent losses. Although there was a minor improvement in EBIT and EBITDA margins in 2024, they remain relatively low. The gross profit margin has also decreased, reflecting cost pressures or pricing challenges. Overall, the income statement portrays a company struggling to maintain profitability and revenue growth.

Balance Sheet

The balance sheet shows a strong equity base with a favorable equity ratio, suggesting financial stability. However, the decreasing stockholders' equity and total assets indicate potential asset erosion. The debt-to-equity ratio remains low, which is positive, yet the decreasing assets and equity raise concerns about long-term sustainability. While the company maintains a good liquidity position due to high cash reserves, the trend of shrinking equity poses potential risks.

Cash Flow

Camellia's cash flow statement highlights significant challenges with consistently negative free cash flow and operating cash flow over recent years. This situation indicates difficulties in generating cash from operations and suggests reliance on external financing or asset sales to cover capital expenditures. The operating cash flow to net income ratio is poor, reflecting inefficiencies in cash conversion. Overall, the cash flow position suggests financial strain and potential liquidity risks.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	262.20M	272.30M	297.20M	277.20M	291.20M
Gross Profit	49.00M	67.00M	70.50M	61.80M	63.50M
EBITDA	13.30M	16.20M	12.70M	17.70M	17.80M
Net Income	-4.90M	-3.70M	-15.90M	4.50M	-800.00K
Balance Sheet
Total Assets	476.30M	499.70M	571.80M	593.50M	582.30M
Cash, Cash Equivalents and Short-Term Investments	139.10M	48.90M	50.60M	65.80M	98.50M
Total Debt	26.90M	33.20M	30.90M	32.50M	19.90M
Total Liabilities	128.60M	136.40M	154.10M	156.20M	156.30M
Stockholders Equity	308.50M	325.80M	368.90M	388.60M	376.60M
Cash Flow
Free Cash Flow	-12.10M	-26.50M	-20.30M	-22.70M	-900.00K
Operating Cash Flow	-2.60M	-14.90M	-5.90M	-12.00M	12.90M
Investing Cash Flow	58.00M	10.00M	-3.20M	-4.00M	8.30M
Financing Cash Flow	-9.00M	-5.90M	-12.10M	-18.40M	-12.40M

Camellia Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 5725.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CAM, the sentiment is Neutral. The current price of 5725 is below the 20-day moving average (MA) of 5738.75, above the 50-day MA of 5618.93, and above the 200-day MA of 4800.23, indicating a neutral trend. The MACD of 38.36 indicates Positive momentum. The RSI at 49.88 is Neutral, neither overbought nor oversold. The STOCH value of 31.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:CAM.

Camellia Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MPE	80 Outperform	£689.78M	10.17	17.13%	2.66%	11.71%	65.23%
AEP	77 Outperform	£487.96M	7.23	16.51%	3.05%	16.42%	33.12%
RE	66 Neutral	£42.95M	3.04	11.67%	―	3.46%	―
Sector *	63 Neutral	$20.46B	14.51	-3.60%	3.15%	2.60%	-5.31%
CAM	55 Neutral	£144.08M	―	-1.36%	4.56%	-3.71%	-15.89%
CARR	54 Neutral	£77.58M	―	-6.03%	2.89%	―	―
DKL	51 Neutral	£6.01M	―	-37.67%	―	-23.72%	23.19%

Camellia Corporate Events

Camellia Plc Completes Sale of Leesh River Estate

Camellia Plc has announced the completion of the sale of Goodricke Group Ltd’s Leesh River estate, aligning with its Value Enhancement Plan aimed at improving operational results and reducing risk. This strategic move is expected to streamline operations and potentially enhance shareholder value by focusing on core assets.

Camellia Plc Announces Change in Voting Rights Structure

Camellia Plc, a company involved in the acquisition and disposal of voting rights, has announced a change in its voting rights structure due to the purchase and cancellation of shares. This adjustment has resulted in an increase in the percentage of voting rights held by Nokia Bell Pensioenfonds OFP, a shareholder based in Antwerpen, Belgium, to 14.80%. This change reflects a significant shift in the company’s shareholder structure, potentially impacting its governance and decision-making processes.

Camellia PLC Sees Major Shareholder Divestment

Camellia PLC has announced a significant change in its shareholding structure as Quaero Capital SA, based in Geneva, Switzerland, has reduced its stake in the company. The notification indicates that Quaero Capital SA has decreased its holdings from 3.939202% to 0%, suggesting a complete divestment of its shares in Camellia PLC. This development could have implications for the company’s market perception and investor relations, as it reflects a shift in the confidence or strategy of a major shareholder.

Camellia PLC Announces Change in Voting Rights Structure

Camellia PLC has announced a change in its voting rights structure following a passive crossing of the 3% threshold due to a tender offer by the issuer. This notification, involving XIX-INVEST NV based in Antwerp, Belgium, indicates a shift in shareholder voting dynamics, potentially impacting the company’s governance and decision-making processes.

Camellia PLC Increases Voting Rights Control

Camellia PLC has announced a significant change in its voting rights structure due to the issuer’s purchase and cancellation of shares, which has led to an increase in voting rights percentage. The Camellia Private Trust Company Limited, as Trustee of The Camellia Foundation, now holds 56.45% of the voting rights, indicating a substantial control over the company. This change could impact the company’s governance and decision-making processes, potentially affecting stakeholders and market perception.

Camellia plc Completes Tender Offer, Adjusts Voting Rights

Camellia plc announced the results of its Tender Offer, where 215,084 Ordinary Shares were validly tendered, representing 7.8% of the company’s issued share capital. This resulted in a total return of approximately £11.6 million to shareholders. Following the tender, the total number of voting rights in Camellia is now 2,527,795, which shareholders can use as a reference for any changes in their interests under the FCA’s rules.

Camellia plc Announces Successful AGM and Tender Offer Approval

Camellia plc successfully held its 2025 Annual General Meeting, where all proposed resolutions, including the approval of the final dividend and the re-election of several directors, were passed. Additionally, a General Meeting approved a tender offer resolution, with results to be announced on 6 June 2025, potentially impacting shareholder value and market perception.

Camellia PLC Announces £18.9 Million Share Buyback Through Tender Offer

Camellia PLC has announced a proposed return of capital to its shareholders through a Tender Offer, aiming to repurchase up to 350,000 Ordinary Shares at a price of £54.00 per share, totaling up to £18.9 million. This move follows the company’s recent disposal of its shares in BF&M, which generated significant surplus funds, and is part of a broader strategy to optimize its balance sheet and return value to shareholders. The Tender Offer represents a premium over recent share prices and is subject to shareholder approval at an upcoming General Meeting.

Camellia Plc Unveils Strategic Value Enhancement Plan

Camellia Plc has announced a Value Enhancement Plan (VEP) aimed at generating sustainable profitability and long-term shareholder value through improved operating performance, risk reduction, and growth investment. The plan includes a proposed tender offer of up to 350,000 shares at £54.00 per share, totaling £18.9 million. The VEP focuses on enhancing operating results by optimizing land and factory utilization, advancing technology, and improving crop strategies. It also seeks to mitigate risks through diversification and strategic disposals while exploring growth opportunities in familiar crops and geographies. The company’s strengthened balance sheet and strategic capital allocation priorities, including a return to ordinary dividends, underpin these initiatives.

Camellia PLC Increases Voting Rights to 52.005% After Share Buy-Back

Camellia PLC has announced an increase in its voting rights percentage following a buy-back and cancellation of shares. The Camellia Private Trust Company Limited, as Trustee of The Camellia Foundation, now holds 52.005% of the voting rights, indicating a significant control over the company, which could impact its strategic decisions and stakeholder interests.